Leslie W. Kreis - Net Worth and Insider Trading

Leslie W. Kreis Net Worth

The estimated net worth of Leslie W. Kreis is at least $22 Million dollars as of 2024-05-09. Leslie W. Kreis is the Director, 10% Owner of Cognition Therapeutics Inc and owns about 5,499,905 shares of Cognition Therapeutics Inc (CGTX) stock worth over $11 Million. Leslie W. Kreis is the 10% Owner of Lantern Pharma Inc and owns about 1,263,802 shares of Lantern Pharma Inc (LTRN) stock worth over $8 Million. Leslie W. Kreis is also the 10% Owner of Azitra Inc and owns about 6,743,383 shares of Azitra Inc (AZTR) stock worth over $2 Million. Besides these, Leslie W. Kreis also holds IN8bio Inc (INAB) . Details can be seen in Leslie W. Kreis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leslie W. Kreis has not made any transactions after 2024-02-29 and currently still holds the listed stock(s).

Transaction Summary of Leslie W. Kreis

To

Leslie W. Kreis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leslie W. Kreis owns 4 companies in total, including Lantern Pharma Inc (LTRN) , Cognition Therapeutics Inc (CGTX) , and IN8bio Inc (INAB) among others .

Click here to see the complete history of Leslie W. Kreis’s form 4 insider trades.

Insider Ownership Summary of Leslie W. Kreis

Ticker Comapny Transaction Date Type of Owner
LTRN Lantern Pharma Inc 2024-02-29 10 percent owner
CGTX Cognition Therapeutics Inc 2022-11-28 director & 10 percent owner
INAB IN8bio Inc 2022-12-12 director & 10 percent owner
2023-06-21 10 percent owner

Leslie W. Kreis Latest Holdings Summary

Leslie W. Kreis currently owns a total of 4 stocks. Among these stocks, Leslie W. Kreis owns 5,499,905 shares of Cognition Therapeutics Inc (CGTX) as of November 28, 2022, with a value of $11 Million and a weighting of 50.11%. Leslie W. Kreis owns 1,263,802 shares of Lantern Pharma Inc (LTRN) as of February 29, 2024, with a value of $8 Million and a weighting of 37.31%. Leslie W. Kreis also owns 6,743,383 shares of Azitra Inc (AZTR) as of June 21, 2023, with a value of $2 Million and a weighting of 7.99%. The other 1 stocks IN8bio Inc (INAB) have a combined weighting of 4.59% among all his current holdings.

Latest Holdings of Leslie W. Kreis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGTX Cognition Therapeutics Inc 2022-11-28 5,499,905 2.00 10,999,810
LTRN Lantern Pharma Inc 2024-02-29 1,263,802 6.48 8,189,437
AZTR Azitra Inc 2023-06-21 6,743,383 0.26 1,753,280
INAB IN8bio Inc 2022-12-12 997,433 1.01 1,007,407

Holding Weightings of Leslie W. Kreis


Leslie W. Kreis Form 4 Trading Tracker

According to the SEC Form 4 filings, Leslie W. Kreis has made a total of 3 transactions in Cognition Therapeutics Inc (CGTX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cognition Therapeutics Inc is the acquisition of 16,064 shares on November 28, 2022, which cost Leslie W. Kreis around $42,570.

According to the SEC Form 4 filings, Leslie W. Kreis has made a total of 5 transactions in Lantern Pharma Inc (LTRN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Lantern Pharma Inc is the sale of 144,000 shares on February 29, 2024, which brought Leslie W. Kreis around $676,800.

According to the SEC Form 4 filings, Leslie W. Kreis has made a total of 1 transactions in Azitra Inc (AZTR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Azitra Inc is the acquisition of 2,297,490 shares on June 21, 2023, which cost Leslie W. Kreis around $11 Million.

More details on Leslie W. Kreis's insider transactions can be found in the Insider Trading History of Leslie W. Kreis table.

Insider Trading History of Leslie W. Kreis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leslie W. Kreis Trading Performance

GuruFocus tracks the stock performance after each of Leslie W. Kreis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leslie W. Kreis is -14.07%. GuruFocus also compares Leslie W. Kreis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leslie W. Kreis within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Leslie W. Kreis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Leslie W. Kreis

Average Return

Average return per transaction

Outperforming Transactions

0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.98
Relative Return to S&P 500(%) 21.15

Leslie W. Kreis Ownership Network

Ownership Network List of Leslie W. Kreis

No Data

Ownership Network Relation of Leslie W. Kreis


Leslie W. Kreis Owned Company Details

What does Lantern Pharma Inc do?

Who are the key executives at Lantern Pharma Inc?

Leslie W. Kreis is the 10 percent owner of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Bios Fund I, Lp , 10 percent owner Fletcher Aaron G.l. , and 10 percent owner Bios Capital Management, Lp .

Lantern Pharma Inc (LTRN) Insider Trades Summary

Over the past 18 months, Leslie W. Kreis made 3 insider transaction in Lantern Pharma Inc (LTRN) with a net sale of 348,237. Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 348,237 shares made by Bios Fund I, Lp ,

In summary, during the past 3 months, insiders sold 288,000 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 288,000 shares. During the past 18 months, 696,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 696,474 shares.

Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lantern Pharma Inc Insider Transactions

No Available Data

Leslie W. Kreis Mailing Address

Above is the net worth, insider trading, and ownership report for Leslie W. Kreis. You might contact Leslie W. Kreis via mailing address: 1751 River Run, Suite 400, Fort Worth Tx 76107.

Discussions on Leslie W. Kreis

No discussions yet.